Find your next paid study

Covenant Health Cancer CenterNCT06200259

Actual pay is set by the research site.

Characterizing the EEG Signature of Fentanyl and Its Association With Drug Liking

The goal of this study is to characterize an electroencephalogram (EEG) biomarker for fentanyl and understand where this signal is coming from in the brain. Th…

Brain Activity Related to Opioid AdministrationBrain Activity Related to Drug Liking

Stanford UniversityNCT06699953

Actual pay is set by the research site.

The Canopy Cancer Collective Clinical Registry Protocol

The Canopy Cancer Collective Clinical Registry Protocol Non-Interventional Data and Sample Collection Registry Protocol Number of study sites 15 Study Design …

Gastrointestinal NeoplasmsPancreatic CancerColorectal Cancer+4 more

Canopy Cancer Collective, LLCNCT07605702

~$10 – $1,050

Actual pay is set by the research site.

Advanced Renal Cell CarcinomaAdvanced Melanoma

A Phase 1b Study of Sitagliptin in Combination With Pembrolizumab in Refractory or Relapsed Advanced Renal Cell Carcinoma and Melanoma

This study is testing whether adding the drug sitagliptin to the standard immunotherapy pembrolizumab is safe and may help people with advanced melanoma or adv…

Fernando Maciel BarbosaNCT07634380

~$150 – $4,500

Actual pay is set by the research site.

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmMetastatic Pancreatic Adenocarcinoma+5 more

A Phase 1 Study of Bisaminoquinoline Derivative (TR-002) for Injection for Advanced Treatment-Refractory Solid Tumors

This phase I trial tests the safety, side effects and best dose of TR-002 for the treatment of solid tumors that may have spread from where it first started to…

University of California, DavisNCT07189195

~$150 – $3,000

Actual pay is set by the research site.

Observational

ACP Educator Video Program to Promote Goal-Concordant Care in Older Patients and Those With Alzheimer's Disease and Related Dementias: Advancing Ethical Goals In Society (AEGIS)

The goal of this clinical trial is to make sure that the values of older persons aged 65 years or older with Alzheimer's Disease and Related Dementias (ADRD) o…

Advance Care PlanningDementiaAlzheimer's Disease

Tufts Medical CenterNCT07824245

Actual pay is set by the research site.

Phase 4

Comparison of Outcomes of Management of Bowel Obstruction

The Comparison of Outcomes of Management of Bowel Obstruction (COMBO) trial is a patient-level randomized trial of a short course of dexamethasone + supportive…

Adhesive Small Bowel Obstruction

University of WashingtonNCT07084441

~$25 – $1,000

Actual pay is set by the research site.

Locally Advanced or Metastatic Malignant Solid Tumors

A Phase 1b/2 Study of ASP2998 as Monotherapy and in Combination With Standard Therapies in Participants With Locally Advanced Unresectable or Metastatic Solid Tumors

Specific proteins found in tumors help the tumors spread and grow. People with solid tumors often have a protein called TROP2 in their tumor. ASP2998 is being …

Astellas Pharma Global Development, Inc.NCT07287995

~$150 – $4,200

Actual pay is set by the research site.

Observational

Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

This phase II trial studies the side effects of hypofractionated radiation therapy in treating patients with soft tissue sarcomas prior to surgery. Hypofractio…

Recurrent Adult Soft Tissue Sarcoma

Jonsson Comprehensive Cancer CenterNCT02701153

Actual pay is set by the research site.

Phase 2

A Phase 2 Trial of Chemotherapy, Pembrolizumab, and Propranolol in Advanced Esophageal/Gastroesophageal Junction Adenocarcinoma Patients

This phase II trial tests what effects the addition of propranolol to pembrolizumab and standard chemotherapy (mFOLFOX) may have on response to treatment in pa…

Clinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+8 more

~$75 – $3,000

Actual pay is set by the research site.

HERO Trial: Phase I Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents in Localized Bladder Cancer

In this study, we aim to evaluate the safety and efficacy of neoadjuvant combination using intravesical romidepsin and durvalumab in cisplatin-ineligible patie…

Bladder Cancer

H. Lee Moffitt Cancer Center and Research InstituteNCT06963346

~$150 – $3,000

Actual pay is set by the research site.

Cervical Esophagus AdenocarcinomaClinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8+10 more

A Phase 1 Study of NBTXR3 Activated by Radiotherapy With Concurrent Chemotherapy for Adenocarcinoma of the Esophagus

The purpose of this Phase I study is to determine the recommended phase 2 dose (RP2D) and safety profile of NBTXR3 activated by radiation therapy with concurre…